Table 2.
Summary of HPV data for 98 patients with mucoepidermoid carcinoma
| HPV16+ only (n = 22) | HPV18+ only (n = 6) | HPV16+/18+ (n = 7) | HPV-negative (n = 63) | |
|---|---|---|---|---|
| Female: male | 1.75:1 | 2:1 | 1:1.3 | 3.2:1 |
| Mean age | 48 | 48 | 48 | 51 |
| Major salivary sites | 27 % (6/22) | 33 % (2/6) | 43 % (3/7) | 17 % (11/63) |
| Oropharyngeal sites | 5 % (1/22) | 17 % (1/6) | 0 | 3 % (2/63) |
| Oral cavity sites | 68 % (15/22) | 50 % (3/6) | 57 % (4/7) | 79 % (50/63) |
| 1977–2000 | 50 % (11/22) | 0 | 0 | 54 % (34/63) |
| 2001–2010 | 50 % (11/22) | 100 % (6/6) | 100 % (7/7) | 46 % (29/63) |
| MEC1-MAML2 translocation | 77 % (10/13) | 66 % (2/3) | 25 % (1/4) | 59 % (10/17) |